Among the genes that showed significant enrichment of short variants in DTBC over LumA tumors was TP53, a well-documented tumor suppressor gene [71]; it was mutated in 76% of DTBC tumors compared to only 18% of LumA tumors (Fig. 2B and Table S2A). This evidence concerns the gene TP53 and neoplasm.